(Q33924902)

English

Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

echocardiography

1 reference

based on heuristic

inferred from title

transesophageal echocardiography

1 reference

based on heuristic

inferred from title

atrial fibrillation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Naccarelli GV

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dell'Orfano JT

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Wolbrette DL

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Patel HM

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Luck JC

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

85

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

10A

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

36D-45D

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Clinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Verapamil reduces tachycardia-induced electrical remodeling of the atria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Alterations in cardiac sarcoplasmic reticulum Ca2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atri

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Electrical remodeling in atrial fibrillation. Time course and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Intravenous amiodarone. Another option in the acute management of sustained ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Effectiveness of amiodarone and electrical cardioversion for chronic rheumatic atrial fibrillation after mitral valve surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Electrophysiology and pharmacology of ibutilide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Electrical reversion of cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Optimal technique for electrical cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Relation between echocardiographically determined left atrial size and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

A randomized comparison of external and internal cardioversion of chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Cost effectiveness of administration of intravenous anesthetics for direct-current cardioversion by nonanesthesiologists.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: a decision analytic model for patients admitted to the hospital with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

National use of the transesophageal echocardiographic-guided approach to cardioversion for patients in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900905-X

7 January 2021

Identifiers

10.1016/S0002-9149(00)00905-X

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33924902&oldid=1979576265"